Viemed Healthcare, Inc. (VMD) Reports In-Line Q2 EPS

Viemed Healthcare, Inc. (NASDAQ: VMD) reported Q2 EPS of $0.06, in-line with the analyst estimate of $0.06. Revenue for the quarter came in at $43.3 million versus the consensus estimate of $40.83 million.

For earnings history and earnings-related data on Viemed Healthcare, Inc. (VMD) click here.

You May Also Be Interested In

• Stran & Company, Inc. (SWAG) Reports Q2 EPS of $0.02
• Snail, Inc. (SNAL) Reports Q3 Loss of $0.36
• Transact Technologies (TACT) Tops Q2 EPS by 1c